← brief for 2026-08-14 · People & money

Dose Conversion Ratio Between Roxadustat and Daprodustat in Patients With Non-dialysis Chronic Kidney Disease

Paper B Peer reviewed Small trial

Key takeaways

A study of 100 patients with anemia found that Roxadustat and Daprodustat doses could be swapped safely. The study lasted 24 weeks.

Who did this work

Keiji Hirai · Junki Morino · Katsunori Yanai · Yuko Mutsuyoshi · Taisuke Kitano · Haruhisa Miyazawa · Kiyonori Ito · Takahiro Masuda · Susumu Ookawara · Yoshiyuki Morishita

Source

Paper · OpenAlex, Kidney disease concept sweep (verified C2778653478) · 2026-08-13
https://doi.org/10.7759/cureus.114463